The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Saved in:
| Title: | The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. |
|---|---|
| Authors: | Steinberg MH; Department of Medicine, Boston University School of Medicine, Boston Medical Center, Massachusetts, USA. mhsteinb@bu.edu |
| Corporate Authors: | Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up |
| Source: | American journal of hematology [Am J Hematol] 2010 Jun; Vol. 85 (6), pp. 403-8. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
